 Melanie Joy
Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cisplatin | 4 | 2024 | 327 | 2.500 |
Why?
| | Acute Kidney Injury | 5 | 2024 | 812 | 1.310 |
Why?
| | Antineoplastic Agents | 4 | 2024 | 2153 | 1.310 |
Why?
| | Kidney | 4 | 2025 | 1467 | 0.990 |
Why?
| | Serotonin 5-HT3 Receptor Antagonists | 1 | 2024 | 5 | 0.910 |
Why?
| | Nephritis, Interstitial | 1 | 2025 | 12 | 0.910 |
Why?
| | Platinum | 1 | 2024 | 52 | 0.880 |
Why?
| | Antiemetics | 1 | 2024 | 46 | 0.870 |
Why?
| | Lupus Nephritis | 1 | 2021 | 65 | 0.690 |
Why?
| | Pharmacogenomic Variants | 1 | 2017 | 33 | 0.530 |
Why?
| | Models, Biological | 1 | 2024 | 1810 | 0.530 |
Why?
| | Neoplasms | 2 | 2024 | 2689 | 0.510 |
Why?
| | Biomarkers | 4 | 2024 | 4095 | 0.290 |
Why?
| | Milrinone | 2 | 2018 | 25 | 0.260 |
Why?
| | Creatinine | 2 | 2018 | 486 | 0.250 |
Why?
| | Granisetron | 1 | 2024 | 6 | 0.230 |
Why?
| | Quinuclidines | 1 | 2024 | 9 | 0.230 |
Why?
| | Ondansetron | 1 | 2024 | 18 | 0.230 |
Why?
| | Ipilimumab | 1 | 2025 | 32 | 0.230 |
Why?
| | Isoquinolines | 1 | 2024 | 45 | 0.220 |
Why?
| | CTLA-4 Antigen | 1 | 2025 | 99 | 0.220 |
Why?
| | Glomerular Filtration Rate | 2 | 2018 | 741 | 0.210 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2025 | 254 | 0.190 |
Why?
| | Disease Models, Animal | 2 | 2025 | 4319 | 0.190 |
Why?
| | Mice | 3 | 2025 | 17836 | 0.190 |
Why?
| | Imatinib Mesylate | 1 | 2021 | 80 | 0.180 |
Why?
| | Prospective Studies | 3 | 2024 | 7666 | 0.170 |
Why?
| | Particle Size | 1 | 2021 | 391 | 0.160 |
Why?
| | Fructose | 1 | 2018 | 113 | 0.140 |
Why?
| | Female | 7 | 2025 | 74071 | 0.140 |
Why?
| | Animals | 4 | 2025 | 37261 | 0.140 |
Why?
| | Organic Cation Transporter 2 | 1 | 2017 | 8 | 0.140 |
Why?
| | Glutathione S-Transferase pi | 1 | 2017 | 10 | 0.140 |
Why?
| | Multidrug Resistance-Associated Proteins | 1 | 2017 | 35 | 0.130 |
Why?
| | Organic Cation Transport Proteins | 1 | 2017 | 25 | 0.130 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3399 | 0.130 |
Why?
| | Humans | 10 | 2025 | 139072 | 0.130 |
Why?
| | Aged | 3 | 2024 | 24186 | 0.130 |
Why?
| | Cation Transport Proteins | 1 | 2017 | 109 | 0.120 |
Why?
| | Regression Analysis | 1 | 2018 | 1021 | 0.120 |
Why?
| | Male | 7 | 2024 | 68299 | 0.120 |
Why?
| | Glomerulosclerosis, Focal Segmental | 1 | 2015 | 45 | 0.120 |
Why?
| | Glucuronosyltransferase | 1 | 2015 | 17 | 0.110 |
Why?
| | Glucuronides | 1 | 2015 | 19 | 0.110 |
Why?
| | Middle Aged | 3 | 2024 | 33811 | 0.110 |
Why?
| | Carcinoma, Renal Cell | 1 | 2015 | 212 | 0.090 |
Why?
| | Complement Activation | 1 | 2015 | 403 | 0.090 |
Why?
| | Kidney Neoplasms | 1 | 2015 | 395 | 0.080 |
Why?
| | Liver | 1 | 2018 | 1807 | 0.080 |
Why?
| | Adult | 3 | 2024 | 38428 | 0.080 |
Why?
| | Critical Illness | 1 | 2016 | 837 | 0.080 |
Why?
| | Retrospective Studies | 1 | 2017 | 15919 | 0.040 |
Why?
| | Half-Life | 1 | 2018 | 146 | 0.040 |
Why?
| | Biological Availability | 1 | 2018 | 137 | 0.040 |
Why?
| | Tissue Inhibitor of Metalloproteinase-2 | 1 | 2018 | 15 | 0.040 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 1 | 2018 | 25 | 0.040 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 1 | 2018 | 42 | 0.040 |
Why?
| | Area Under Curve | 1 | 2018 | 320 | 0.030 |
Why?
| | Cardiotonic Agents | 1 | 2018 | 95 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2018 | 453 | 0.030 |
Why?
| | ROC Curve | 1 | 2018 | 564 | 0.030 |
Why?
| | Administration, Oral | 1 | 2018 | 788 | 0.030 |
Why?
| | Thoracic Surgery | 1 | 2018 | 139 | 0.030 |
Why?
| | Metabolic Clearance Rate | 1 | 2016 | 116 | 0.030 |
Why?
| | Complement C5b | 1 | 2015 | 5 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 348 | 0.030 |
Why?
| | Vasodilator Agents | 1 | 2016 | 329 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 620 | 0.030 |
Why?
| | Glucose | 1 | 2018 | 1032 | 0.030 |
Why?
| | Pharmaceutical Preparations | 1 | 2015 | 176 | 0.020 |
Why?
| | Pilot Projects | 1 | 2018 | 1766 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2049 | 0.020 |
Why?
| | Rats | 1 | 2018 | 5594 | 0.020 |
Why?
| | Blood Glucose | 1 | 2018 | 2242 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2015 | 2818 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2018 | 6159 | 0.020 |
Why?
| | Child | 2 | 2016 | 21946 | 0.010 |
Why?
| | Infant | 1 | 2018 | 9586 | 0.010 |
Why?
| | Adolescent | 1 | 2015 | 21594 | 0.010 |
Why?
|
|
Joy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|